Allarity Therapeutics, Inc.
ALLR
Revenue
0.00
0.000.00%
-Assets
30.88M
▲18.91M▲158.02%
3 Months ChangeLiabilities
11.05M
▼-7.39M▼-40.09%
3 Months ChangeFree Cash Flow
-16.84M
▼-9.58M▼-132.08%
24 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-23
Form 8-K
ID: 0001437749-24-031806
2024-10-11
Form 8-K
ID: 0001437749-24-031059
2024-10-04
Form 8-K
ID: 0001437749-24-030661
2024-09-17
Form 8-K
ID: 0001213900-24-079165
2024-09-13
Form 8-K
ID: 0001213900-24-078294
2024-09-09
Form 8-K
ID: 0001213900-24-076728
2024-08-21
Form 8-K
ID: 0001213900-24-071499
2024-08-05
Form 10-Q
ID: 0001213900-24-065252
2024-07-23
Form 8-K
ID: 0001213900-24-063581
2024-07-22
Form 8-K
ID: 0001213900-24-063201